Holen Sie sich die Stockscreener-App
145.49
1.91%
-2.83
Handel nachbörslich:
145.49
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$148.32
Offen:
$148.79
24-Stunden-Volumen:
2.10M
Relative Volume:
1.16
Marktkapitalisierung:
$41.18B
Einnahmen:
$6.95B
Nettoeinkommen (Verlust:
$1.30B
KGV:
31.83
EPS:
4.5714
Netto-Cashflow:
$1.15B
1W Leistung:
-5.22%
1M Leistung:
-0.87%
6M Leistung:
+27.69%
1J Leistung:
+5.53%
1-Tages-Spanne:
$144.76
$149.00
1-Wochen-Bereich:
$144.22
$153.95
52-Wochen-Spanne:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Vergleichen Sie A mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent and Monash University Celebrate 15 Years with New BioDiscovery Hub - Nabalu News
Is Agilent Technologies Inc. stock supported by innovation pipelineJuly 2025 Big Picture & Safe Entry Point Identification - Newser
Is Agilent Technologies Inc. stock a top pick for value investorsPortfolio Value Summary & Expert Verified Movement Alerts - Newser
How Agilent Technologies Inc. stock benefits from global expansionPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
Will Agilent Technologies Inc. (AG8) stock outperform global peersWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - Newser
Agilent and Monash University Malaysia Mark 15-Year Partnership with New BioDiscovery Hub to Drive Regional Biotech Innovation - The Malaysian Reserve
Agilent Technologies : and Monash University Malaysia Mark 15-Year Partnership with New BioDiscovery Hub to Drive Regional Biotech Innovation - marketscreener.com
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Looking At Agilent Technologies's Recent Unusual Options Activity - Benzinga
Transcript : Agilent Technologies, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09 - marketscreener.com
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
Jim Cramer on Agilent: "The Thing's Just Caught Fire" - Finviz
Jim Cramer on Agilent: “The Thing’s Just Caught Fire” - Insider Monkey
Insider Sell: Mikael Dolsten Sells Shares of Agilent Technologie - GuruFocus
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Morgan Stanley Initiates Coverage on Agilent Technologies (NYSE:A) - MarketBeat
Panagora Asset Management Inc. Has $38.71 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Why Agilent Technologies Inc. stock benefits from AI revolutionJuly 2025 Final Week & High Yield Stock Recommendations - Newser
Morgan Stanley Initiates Agilent Technologies at Overweight With $180 Price Target - marketscreener.com
Can Agilent Technologies Inc. (AG8) stock survive global slowdownJuly 2025 Patterns & Weekly High Momentum Picks - Newser
Is Agilent Technologies Inc. stock a momentum leaderGap Up & Safe Entry Trade Signal Reports - Newser
Agilent Technologies (NYSE:A) S&P 500 Fund Marks Broader Scientific Momentum - Kalkine Media
Can Agilent Technologies Inc. stock test all time highs2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - Newser
Morgan Stanley Initiates Coverage of Agilent Technologies (A) with Overweight Recommendation - Nasdaq
Agilent Technologies (NYSE:A) VP Sells $464,970.00 in Stock - MarketBeat
Morgan Stanley initiates Agilent stock with Overweight rating, $180 target By Investing.com - Investing.com Canada
Morgan Stanley Initiates Coverage on Agilent Technologies (A) wi - GuruFocus
Morgan Stanley initiates Agilent stock with Overweight rating, $180 target - Investing.com
Agilent Technologies price driven lower by pivotal resistanceForecast today02-12-2025 - Economies.com
Targeted Sequencing Industry Intelligence 2020-2030 - GlobeNewswire
Targeted Sequencing Industry Intelligence 2020-2030 Featuring Profiles of MGI Tech, GENEWIZ, Agilent Technologies and Other Leading Companies - Yahoo Finance
Is Agilent Technologies Inc. stock good for wealth creationQuarterly Trade Report & Proven Capital Preservation Methods - Newser
New York State Common Retirement Fund Has $33.53 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Skandinaviska Enskilda Banken AB publ Trims Stake in Agilent Technologies, Inc. $A - MarketBeat
3,347,921 Shares in Agilent Technologies, Inc. $A Acquired by Norges Bank - MarketBeat
Can Agilent Technologies Inc. (AG8) stock deliver consistent EPS growthPortfolio Profit Report & Verified Momentum Stock Alerts - Newser
Will Agilent Technologies Inc. (AG8) stock benefit from commodity supercycleCEO Change & Weekly Momentum Picks - Newser
Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight - BioSpace
Why Agilent Technologies Inc. stock stays resilientJuly 2025 Sentiment & Fast Momentum Entry Tips - Newser
Agilent (A) International Revenue Performance Explored - sharewise.com
Rothschild & Co Redburn Adjusts Price Target on Agilent Technologies to $180 From $165, Maintains Buy Rating - marketscreener.com
Agilent announces 21 CFR Part 11 compliance software for Xcelligence RTCA eSight - marketscreener.com
Regulatory-ready live-cell platform for GMP environments - Labmate Online
Agilent Announces 21 Cfr Part 11 Compliance Software For Xcelligence RTCA eSight - TradingView
Agilent Technologies, Inc. $A Shares Sold by Groupama Asset Managment - MarketBeat
Mackenzie Financial Corp Cuts Position in Agilent Technologies, Inc. $A - MarketBeat
Hsbc Holdings PLC Has $95.85 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Quadrant Capital Group LLC Purchases 3,395 Shares of Agilent Technologies, Inc. $A - MarketBeat
Do Wall Street Analysts Like Agilent Technologies Stock? - MSN
Agilent Technologies, Inc. $A Shares Purchased by Vinva Investment Management Ltd - MarketBeat
Agilent Technologies (A): Assessing Valuation Following Strong Q4 Results and Upbeat 2026 Guidance - simplywall.st
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):